5-Amino-1MQ
10 mgInvestigational small molecule; naming as a peptide would be inaccurate.
Explore product information →KALO Clinical
KALO CLINICAL · PRODUCT ATLAS
Explore the collection
Educational references · not offers for sale
32 development records and strength variants, each with its own educational detail page. Listings are not offers for sale, proof of FDA approval, or verification of manufacturing claims.
No matching products. Try a different name, strength, or status.
5-Amino-1MQ
50 mgInvestigational small molecule; naming as a peptide would be inaccurate.
Explore product information →AOD (variant unverified)
10 mgCompound suffix and exact chemical identity require verification.
Explore product information →BPC-157
10 mgInvestigational peptide. Human safety, efficacy, and approved indications have not been established.
Explore product information →CJC & IPA
10 mgBlend ratio, ingredient specifications and identity require verification.
Explore product information →Epitalon
10 mgInvestigational peptide; safety and benefits are not established for clinical use.
Explore product information →Epitalon
25 mgInvestigational peptide; safety and benefits are not established for clinical use.
Explore product information →GHK-Cu
100 mgCopper-peptide reference. Intended use and formulation determine applicable regulatory requirements.
Explore product information →Glow
70 mgUnverified blend nickname; constituent ingredients and ratios are not confirmed.
Explore product information →hCG
Strength to confirmStrength unit is unverified: hCG is commonly expressed in IU, not milligrams.
Explore product information →IGF (form unverified)
1 mgExact IGF analogue and product identity are not established.
Explore product information →Ipamorelin
10 mgInvestigational peptide. Product route and regulatory eligibility require review.
Explore product information →Klow
80 mgUnverified blend nickname; constituent ingredients and ratios are not confirmed.
Explore product information →MOTS-C
Strength to confirmInvestigational mitochondrial peptide with limited human evidence.
Explore product information →MT-1
Strength to confirmAbbreviation and exact identity require verification before labeling.
Explore product information →MT-2
Strength to confirmAbbreviation and exact identity require verification before labeling.
Explore product information →NAD+
1000 mgCoenzyme reference. Finished-product form, route and labeling have not been verified.
Explore product information →PT-141
10 mgBremelanotide has an approved prescription product for a specific indication. This vial is not established to be that product.
Explore product information →Retatrutide
10 mgInvestigational metabolic compound; not an FDA-approved retail medication.
Explore product information →Retatrutide
20 mgInvestigational metabolic compound; not an FDA-approved retail medication.
Explore product information →Retatrutide
30 mgInvestigational metabolic compound; not an FDA-approved retail medication.
Explore product information →Selank
Strength to confirmPeptide reference without established U.S. FDA approval for general human use.
Explore product information →Semax
Strength to confirmPeptide reference without established U.S. FDA approval for general human use.
Explore product information →Sermorelin
10 mgPeptide reference: assess current product-specific legal and clinical status.
Explore product information →SS-31
10 mgElamipretide reference; approval and applicability depend on the specific drug product and indication.
Explore product information →SS-31
50 mgElamipretide reference; approval and applicability depend on the specific drug product and indication.
Explore product information →TB-500
10 mgPeptide reference: verify exact molecular identity and source; no claim of FDA approval.
Explore product information →Tesamorelin
Strength to confirmPrescription-active ingredient; approved product indications and instructions are formulation-specific.
Explore product information →Tirzepatide
10 mgThe drug substance has FDA-approved prescription products; this KALO listing is not an approved product.
Explore product information →Tirzepatide
20 mgThe drug substance has FDA-approved prescription products; this KALO listing is not an approved product.
Explore product information →Tirzepatide
30 mgThe drug substance has FDA-approved prescription products; this KALO listing is not an approved product.
Explore product information →Wolverine
20 mgBlend nickname; ingredient identities and proportions require supplier verification.
Explore product information →Educational reference library12 ingredient references
CLINICAL REFERENCE CATALOG
Educational reference library
These names are included for scientific and regulatory education. Listing them does not imply availability, safety, efficacy or FDA approval. Sales remain disabled pending product-specific review.
REFERENCE ONLY · NO CHECKOUT
BPC-157
Investigational peptide; human safety and efficacy have not been established.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
TB-500
Peptide reference; identify exact chemical identity and regulatory status.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
Retatrutide
Investigational metabolic drug; not an FDA-approved retail product.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
Tirzepatide
Prescription medicine; FDA-approved formulations have specific indications and labeling.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
GHK-Cu
Copper peptide; regulatory status depends on formulation and intended use.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
NAD+
Biochemical coenzyme; product route, formulation and claims require separate review.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
Tesamorelin
A prescription-drug active ingredient with product-specific approved labeling.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
Semax
Investigational peptide; do not infer medical approval.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
Selank
Investigational peptide; do not infer medical approval.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
SS-31
Mitochondrial peptide reference; approved uses and formulation are product specific.
VIEW REFERENCE →REFERENCE ONLY · NO CHECKOUT
PT-141
Peptide reference; FDA-approved bremelanotide products have specific indications.
VIEW REFERENCE →Clinical design & documentationOriginal packaging artwork & resources
CLINICAL DESIGN SYSTEM
A premium professional-facing identity with transparent documentation, scientific education and careful separation of approved and investigational product information.
Precision in presentation. Responsibility in practice.
The KALO Clinical design uses matte black, thermal gold and lot-level traceability. Product descriptions, labeling, claims and access must follow the applicable regulatory pathway.
For Professional Use Only / Use Under Medical Supervision is a design-language concept—not proof that a particular drug is authorized for human use or sale.